Visterra, Inc. Announces Additions To Its Management Team And Board Of Directors

Visterra, Inc., a biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel therapeutics, today announced two key additions to the company’s executive management team and board of directors. José M. Trevejo, MD, PhD, has been appointed Vice President of Development and Akshay Vaishnaw, MD, PhD, of Alnylam Pharmaceuticals, Inc. has been elected to the company’s board of directors.

Help employers find you! Check out all the jobs and post your resume.